🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/01/2022 | 69,69 | 73,86 | 69,50 | 71,23 | +0,44% | 6,25% | 321.241 |
| 20/01/2022 | 73,01 | 74,57 | 70,72 | 70,92 | -1,97% | 5,27% | 167.994 |
| 19/01/2022 | 72,91 | 75,86 | 72,25 | 72,35 | -0,71% | 4,95% | 187.070 |
| 18/01/2022 | 76,14 | 76,28 | 72,60 | 72,86 | -6,49% | 4,84% | 300.082 |
| 14/01/2022 | 77,01 | 77,98 | 72,71 | 77,92 | -0,34% | 6,84% | 354.423 |
| 13/01/2022 | 79,23 | 80,49 | 77,20 | 78,18 | -1,08% | 4,15% | 352.339 |
| 12/01/2022 | 87,75 | 89,38 | 77,65 | 79,04 | -9,70% | 13,37% | 440.825 |
| 11/01/2022 | 91,48 | 93,04 | 87,23 | 87,53 | -4,45% | 6,36% | 203.741 |
| 10/01/2022 | 89,07 | 92,06 | 87,98 | 91,61 | +1,53% | 4,59% | 144.110 |
| 07/01/2022 | 90,01 | 92,94 | 89,24 | 90,22 | +0,09% | 4,11% | 184.185 |
| 06/01/2022 | 88,55 | 92,26 | 86,23 | 90,14 | +2,58% | 6,81% | 127.599 |
| 05/01/2022 | 92,36 | 94,26 | 87,76 | 87,87 | -5,85% | 7,04% | 195.245 |
| 04/01/2022 | 94,99 | 95,35 | 92,60 | 93,33 | -1,29% | 2,90% | 163.346 |
| 03/01/2022 | 96,39 | 97,49 | 93,11 | 94,55 | -1,88% | 4,54% | 191.879 |
| 31/12/2021 | 97,54 | 99,75 | 96,10 | 96,36 | -1,09% | 3,74% | 109.325 |
| 30/12/2021 | 101,07 | 102,83 | 97,15 | 97,42 | -4,11% | 5,62% | 135.934 |
| 29/12/2021 | 97,87 | 102,05 | 97,87 | 101,60 | +3,27% | 4,27% | 200.054 |
| 28/12/2021 | 99,51 | 102,08 | 98,28 | 98,38 | -1,45% | 3,82% | 129.362 |
| 27/12/2021 | 100,46 | 101,07 | 98,46 | 99,83 | -0,72% | 2,60% | 128.881 |
| 23/12/2021 | 97,69 | 102,61 | 97,10 | 100,55 | +3,01% | 5,64% | 227.947 |
| 22/12/2021 | 94,90 | 98,05 | 93,97 | 97,61 | +3,61% | 4,31% | 197.169 |
| 21/12/2021 | 95,46 | 95,51 | 91,04 | 94,21 | -1,43% | 4,69% | 170.559 |
| 20/12/2021 | 91,45 | 96,38 | 89,58 | 95,58 | +4,92% | 7,44% | 234.198 |
| 17/12/2021 | 87,27 | 95,33 | 86,13 | 91,10 | +4,47% | 10,54% | 1.054.934 |
| 16/12/2021 | 91,97 | 93,54 | 86,62 | 87,20 | -5,23% | 7,53% | 193.963 |
| 15/12/2021 | 88,63 | 92,02 | 84,42 | 92,02 | +3,02% | 8,57% | 322.043 |
| 14/12/2021 | 88,81 | 90,22 | 87,49 | 89,32 | +0,13% | 3,08% | 170.399 |
| 13/12/2021 | 90,42 | 92,40 | 89,13 | 89,20 | -0,67% | 3,62% | 138.339 |
| 10/12/2021 | 89,44 | 92,03 | 88,60 | 89,81 | +0,48% | 3,84% | 123.591 |
| 09/12/2021 | 96,39 | 96,51 | 89,33 | 89,38 | -7,76% | 7,45% | 174.567 |